These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 20061161

  • 21. Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
    Navidpour L, Amini M, Shafaroodi H, Abdi K, Ghahremani MH, Dehpour AR, Shafiee A.
    Bioorg Med Chem Lett; 2006 Sep 01; 16(17):4483-7. PubMed ID: 16806914
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors.
    Fioravanti R, Bolasco A, Manna F, Rossi F, Orallo F, Ortuso F, Alcaro S, Cirilli R.
    Eur J Med Chem; 2010 Dec 01; 45(12):6135-8. PubMed ID: 20974503
    [Abstract] [Full Text] [Related]

  • 23. Selective COX-2 inhibitors. Part 1: synthesis and biological evaluation of phenylazobenzenesulfonamides.
    Tsai WJ, Shiao YJ, Lin SJ, Chiou WF, Lin LC, Yang TH, Teng CM, Wu TS, Yang LM.
    Bioorg Med Chem Lett; 2006 Sep 01; 16(17):4440-3. PubMed ID: 16814546
    [Abstract] [Full Text] [Related]

  • 24. Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity.
    Biava M, Porretta GC, Poce G, Supino S, Forli S, Rovini M, Cappelli A, Manetti F, Botta M, Sautebin L, Rossi A, Pergola C, Ghelardini C, Vivoli E, Makovec F, Anzellotti P, Patrignani P, Anzini M.
    J Med Chem; 2007 Nov 01; 50(22):5403-11. PubMed ID: 17915854
    [Abstract] [Full Text] [Related]

  • 25. Design, syntheses, biological evaluation, and docking studies of 2-substituted 5-methylsulfonyl-1-phenyl-1H-indoles: potent and selective in vitro cyclooxygenase-2 inhibitors.
    Cruz-López O, Díaz-Mochón JJ, Campos JM, Entrena A, Núñez MT, Labeaga L, Orjales A, Gallo MA, Espinosa A.
    ChemMedChem; 2007 Jan 01; 2(1):88-100. PubMed ID: 17131462
    [Abstract] [Full Text] [Related]

  • 26. Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors.
    Dündar Y, Unlü S, Banoğlu E, Entrena A, Costantino G, Nuñez MT, Labeaga L, Sahin MF, Noyanalpan N.
    Eur J Med Chem; 2009 May 01; 44(5):1830-7. PubMed ID: 19084295
    [Abstract] [Full Text] [Related]

  • 27. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
    El-Sayed MA, Abdel-Aziz NI, Abdel-Aziz AA, El-Azab AS, Asiri YA, Eltahir KE.
    Bioorg Med Chem; 2011 Jun 01; 19(11):3416-24. PubMed ID: 21570309
    [Abstract] [Full Text] [Related]

  • 28. Design and synthesis of new 1,3-benzdiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A, Zebardast T, Hajighasemali F, Alipoor E, Daraie B, Hedayati M.
    Arch Pharm (Weinheim); 2012 Apr 01; 345(4):257-64. PubMed ID: 22076641
    [Abstract] [Full Text] [Related]

  • 29. Selective COX-2 inhibitors. Part 2: synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides.
    Lin SJ, Tsai WJ, Chiou WF, Yang TH, Yang LM.
    Bioorg Med Chem; 2008 Mar 01; 16(5):2697-706. PubMed ID: 18063374
    [Abstract] [Full Text] [Related]

  • 30. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A, Najafnia L, Daraee B, Dadrass OG, Hedayati M.
    Bioorg Med Chem Lett; 2007 Oct 15; 17(20):5634-7. PubMed ID: 17822894
    [Abstract] [Full Text] [Related]

  • 31. Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors.
    Eren G, Unlü S, Nuñez MT, Labeaga L, Ledo F, Entrena A, Banoğlu E, Costantino G, Sahin MF.
    Bioorg Med Chem; 2010 Sep 01; 18(17):6367-76. PubMed ID: 20692174
    [Abstract] [Full Text] [Related]

  • 32. Cyclooxygenase-1 and cyclooxygenase-2 inhibition of novel 1,2-disubstituted imidazoles.
    Handler N, Jaeger W, Kuen-Krismer B, Erker T.
    Arch Pharm (Weinheim); 2005 Dec 01; 338(12):602-4. PubMed ID: 16353278
    [Abstract] [Full Text] [Related]

  • 33. Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity.
    Unsal-Tan O, Ozadali K, Piskin K, Balkan A.
    Eur J Med Chem; 2012 Nov 01; 57():59-64. PubMed ID: 23047224
    [Abstract] [Full Text] [Related]

  • 34. Synthesis and biological evaluation of 3-[4-(amino/methylsulfonyl)phenyl]methylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors.
    Lai Y, Ma L, Huang W, Yu X, Zhang Y, Ji H, Tian J.
    Bioorg Med Chem Lett; 2010 Dec 15; 20(24):7349-53. PubMed ID: 21055929
    [Abstract] [Full Text] [Related]

  • 35. Design, Synthesis, and Biological Evaluation of New 2-Phenyl-4H-chromen-4-one Derivatives as Selective Cyclooxygenase-2 Inhibitors.
    Zarghi A, Kakhki S.
    Sci Pharm; 2015 Dec 15; 83(1):15-26. PubMed ID: 26839798
    [Abstract] [Full Text] [Related]

  • 36. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH, Rao PN, Knaus EE.
    Bioorg Med Chem; 2005 Aug 01; 13(15):4694-703. PubMed ID: 15914011
    [Abstract] [Full Text] [Related]

  • 37. Isomeric acetoxy analogs of celecoxib and their evaluation as cyclooxygenase inhibitors.
    Abdur Rahim M, Praveen Rao PN, Bhardwaj A, Kaur J, Huang Z, Knaus EE.
    Bioorg Med Chem Lett; 2011 Oct 15; 21(20):6074-80. PubMed ID: 21890358
    [Abstract] [Full Text] [Related]

  • 38. N-1 and C-3 substituted indole Schiff bases as selective COX-2 inhibitors: synthesis and biological evaluation.
    Kaur J, Bhardwaj A, Huang Z, Knaus EE.
    Bioorg Med Chem Lett; 2012 Mar 15; 22(6):2154-9. PubMed ID: 22361134
    [Abstract] [Full Text] [Related]

  • 39. Design, synthesis and pharmacological evaluation of 4-[2-alkylthio-5(4)-(4-substitutedphenyl)imidazole-4(5)yl]benzenesulfonamides as selective COX-2 inhibitors.
    Salimi M, Ghahremani MH, Naderi N, Amini M, Salimi E, Amanlou M, Abdi K, Salehi R, Shafiee A.
    Acta Pharmacol Sin; 2007 Aug 15; 28(8):1254-60. PubMed ID: 17640491
    [Abstract] [Full Text] [Related]

  • 40. Design, synthesis, and biological evaluation of (E)-3-(4-methanesulfonylphenyl)-2-(aryl)acrylic acids as dual inhibitors of cyclooxygenases and lipoxygenases.
    Moreau A, Chen QH, Praveen Rao PN, Knaus EE.
    Bioorg Med Chem; 2006 Dec 01; 14(23):7716-27. PubMed ID: 16931030
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.